Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03673618 · ClinicalTrials.gov registry record · Phase 2
Soluble Corn Fiber Supplementation for Asthma
A Phase 2 study, sponsored by Phoenix Children's Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 20
- Enrollment target
NCT03673618 is a Phase 2 study that has completed, run by Phoenix Children's Hospital. The registered enrollment target is 20 participants.
The verdict
NCT03673618, a Phase 2 study, has completed, sponsored by Phoenix Children's Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 20 participants
- Enrollment target
Study Summary
Studies of the importance of the human microbiome have demonstrated that microbial metabolites of fermentation of our dietary products (e.g. dietary fiber) have a multitude of health benefits. The investigators aim to determine whether supplementation of asthmatic children with soluble corn fiber alongside standard of care reduces airway inflammation driven by the gut microbial metabolites acetate, propionate, or butyrate (short chain fatty acids).
Interventions
- DRUG Soluble Corn Fiber
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2019-09-01 |
| Est. Completion | 2021-12-31 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03673618
The ClinicalTrials.gov registry entry for NCT03673618 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Phoenix Children's Hospital, which has 26 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Soluble Corn Fiber is the first listed.
NCT03673618 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03673618 about?
NCT03673618 is a clinical study titled "Soluble Corn Fiber Supplementation for Asthma". Studies of the importance of the human microbiome have demonstrated that microbial metabolites of fermentation of our dietary products (e.g. dietary fiber) have a multitude of health benefits. The investigators aim to determine whether supplementation of asthmatic children with soluble corn fiber al...
What is the current status of trial NCT03673618?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 20 participants. The study started on 2019-09-01. Estimated completion is 2021-12-31.
What interventions are being tested in trial NCT03673618?
The interventions under investigation include: Soluble Corn Fiber (DRUG).
Who is sponsoring clinical trial NCT03673618?
This trial is sponsored by Phoenix Children's Hospital, which has 26 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.